The Economist Recognizes JBEI’s CEO Jay Keasling for Anti-Malarial Effort
On Sept. 10, The Economist announced JBEI’s CEO Jay Keasling as the winner of its 2014 Innovation Award in the Bioscience category. In addition to being JBEI’s CEO, Keasling is a Professor of Chemical Engineering at the University of California, Berkeley and Senior Faculty Scientist and Associate Lab Director at Berkeley Lab. He was recognized for his development of synthetic artemisinin used to treat malaria.
iCLEM Featured as a “Cool School” on KPIX-TV
An August 7 KPIX-TV Channel 5 story featured the iCLEM program held at JBEI.